Cologuard Plus — An At-Home Stool DNA Test for Colorectal Cancer Screening

The FDA has approved Cologuard Plus (Exact Sciences), a new at-home multitarget stool DNA test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Cologuard, the first FDA-approved multitarget stool DNA test, has been available since 2014.

Publication Details

Journal: The medical letter on drugs and therapeutics/The medical letter
Published: 2025-05-07
DOI: https://doi.org/10.58347/tml.2025.1728a
Primary Topic: Colorectal Cancer Screening and Detection
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cologuard Plus — An At-Home Stool DNA Test for Colorectal Cancer Screening

May 7, 2025

The medical letter on drugs and therapeutics/The medical letter

Colorectal Cancer Screening and Detection

article

Cologuard Plus — An At-Home Stool DNA Test for Colorectal Cancer Screening

May 7, 2025article en

Abstract

The medical letter on drugs and therapeutics/The medical letterVol. 67(1728)

Good health and well-being

Openalex Percentile: Top 85%

Colorectal Cancer Screening and Detection

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cologuard Plus — An At-Home Stool DNA Test for Colorectal Cancer Screening · The medical letter on drugs and therapeutics/The medical letter (2025) | TGRS Research Map | TGRS